May 05, 2025 13:00
NRXS - Neuraxis, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
3.0 0.35 (11.67%) | --- | --- | --- | -0.03 (-1.0%) | 0.26 (8.41%) | --- | -0.03 (-1.0%) |
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.22
- Diluted EPS:
- -0.22
- Basic P/E:
- -15.2273
- Diluted P/E:
- -15.2273
- RSI(14) 1m:
- 50.0
- VWAP:
- 3.35
- RVol:
- 4.0801
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 3.03 -0.06 (-1.94%) | Oct 15 09:30 |
1m | Price decrease 1m | 2.97 -0.04 (-1.33%) | Oct 15 07:16 |
Related News
Mar 12, 2025 13:00
Jan 21, 2025 18:45
Jan 13, 2025 14:00
Jan 06, 2025 14:00
Sep 19, 2024 13:00
Aug 13, 2024 13:00
Jun 07, 2024 13:00
May 15, 2024 20:30
Apr 09, 2024 20:05